Table 2.

Predictive value of baseline QST on development of CIPN symptoms: multivariate analysis (n = 60, 704 observations)

Effect	Estimate	Standard Error	Pr > |t|
Touch detection
Bumps Detection test	0.109	0.035	0.002
von Frey filament
Painful area	0.218	0.333	0.513
Border area	−0.250	0.476	0.600
Volar area	0.221	0.462	0.633
Sensorimotor function
Grooved Pegboard test
Dominant hand	−0.012	0.008	0.136
Nondominant hand	0.024	0.008	0.002
Other variables
Female vs. male	0.956	0.241	<0.0001
ECOG PS (1–2 vs. 0)	0.607	0.208	0.004
BMI	0.038	0.016	0.020
Opioid use (yes vs. no)	0.567	0.184	0.002

Abbreviations: BMI = body mass index; CIPN = chemotherapy-induced peripheral neuropathy; ECOG PS = Eastern Cooperative Oncology Group performance status; QST = quantitative sensory testing. Multivariate mixed model, with all other factors controlled.